Brief: Thermo Fisher Scientific To Commercialize Devyser's Post-Transplant NGS Products
April 24 (Reuters) - Devyser Diagnostics AB DVYSR.ST :
* ENTERS AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR COMMERCIALIZATION OF DEVYSER'S
POST-TRANSPLANT NGS PRODUCTS
* THERMO FISHER SCIENTIFIC OBTAINS EXCLUSIVE RIGHTS TO COMMERCIALIZE DEVYSER'S
POST-TRANSPLANT
MONITORING PORTFOLIO IN NORTH AMERICA AND EUROPE.
Source text for Eikon: ID:nWkr4Z0L6t
Further company coverage: DVYSR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))